港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

1,339.976

-13.088-0.97%

涨家数：3

跌家数：13

平家数：2

市盈率：- -

高：1,360.659

开：1,353.108

低：1,326.242

收：1,353.064

成交量：2.98亿

成交额：35.74亿

市值：8,945.06亿

流通市值：7,507.53亿

数据加载中...

总览新闻资讯

京东健康携手广州医科大学附属脑科医院启动青少年心理危机AI识别与干预研究项目

比亚迪申请车辆控制方法相关专利，保障车辆及驾乘人员的安全

因劳动合同纠纷，任能站起诉比亚迪等

Tides 周递 | 全球多肽和寡核苷酸药物一周要闻（11.8-11.14）

康希诺施展财技：公积金一次性抹平14.5亿元亏损

中国经营报

出海速递：比亚迪领跑马来西亚电动车市场

人福医药：公司始终专注于医药主业的发展

国药控股主业遇冷，医药流通龙头的增长神话还能延续吗？

华夏时报网

能源仍是涨停热点板块！医药商业逆势崛起，补涨行情来了？

每日经济新闻

刚刚！PD-L1 皮下注射剂在国内获批上市

丁香园肿瘤时间

科兴制药(688136.SH)：科益医药拟询价转让5%公司股份

富祥药业：他唑巴坦、舒巴坦是公司主要医药产品

下个月，460个化学药品，此地医保不予支付！

生物制造被提到新高度创新药、中药等细分领域备受关注

金融投资报

涨价机会梳理：有色+锂电材料+化工+医药（机构闭门会议实录）

新股消息 | 融泰药业拟港股上市中国证监会要求补充说明近一年内新增股东入股价格的合理性等

石药巨石生物SYS6010启动II/III期临床适应症为晚期/转移性食管鳞癌

复星医药：公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进

每日经济新闻

比亚迪发布纯电动轿卡T4：以科技重塑物流，用温度赋能创富

中国汽车报

复星医药(600196.SH)控股子公司药品获美国FDA注册批准

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1515/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":1339.9764,"timestamp":1763366893506,"preClose":1353.0642,"halted":0,"volume":297705183,"delay":0,"changeRate":-0.009673,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-13.087769,"latestTime":"11-17 16:00:00","open":1353.1075,"high":1360.6588,"low":1326.242,"amount":3573610347,"amplitude":0.025436,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"pbRate":2.523293,"peRate":27.182624,"turnoverRate":0.003874,"increases":3,"decrements":13,"flats":1,"marketCap":894506306816,"floatMarketCap":750752559872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1360.6588,"amplitude":0.025436,"preClose":1353.0642,"low":1326.242,"pbRate":"2.523293","latestPrice":1339.9764,"volume":297705183,"delay":0,"open":1353.1075,"prevYearClose":787.97723,"prevWeekClose":1353.064,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1276,"twentyDayClose":1324.309,"sixtyDayClose":1371.762,"secType":"PLATE","market":"HK","turnoverRate":0.003874,"peRate":27.182624,"marketCap":894506306816,"floatMarketCap":750752559872,"timestamp":1763366893506,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":13,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583365512","title":"京东健康携手广州医科大学附属脑科医院 启动青少年心理危机AI识别与干预研究项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2583365512","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583365512?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 16:36","pubTimestamp":1763195807,"startTime":"0","endTime":"0","summary":"11月14日， 京东健康 与广州医科大学附属脑科 医院 儿少科共同宣布，双方正式启动“情绪障碍患者危机数字标志物研究”项目合作，旨在通过融合多模态数据与生成式AI技术，构建青少年及成年早期人群心理危机的动态预警与干预系统，推动心理健康服务向数字化、精准化、主动化方向升级。未来，京东健康将持续深化在精神心理领域的科技布局，推动AI技术在筛查、干预、随访等关键环节的落地应用与迭代优化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115165050976af6ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115165050976af6ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1591","SGXZ62798434.SGD","06078","LU0329678337.USD","LU0737861772.HKD","BK1615","LU2488822045.USD","LU0051755006.USD","SGXZ86797644.SGD","BK1142","BK1247","LU0456827905.SGD","06618","LU0329678170.USD","BK1589","BK1515","BK1571","BK1583","86618","BK1209"],"gpt_icon":0},{"id":"2583634748","title":"比亚迪申请车辆控制方法相关专利，保障车辆及驾乘人员的安全","url":"https://stock-news.laohu8.com/highlight/detail?id=2583634748","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583634748?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 14:21","pubTimestamp":1763187668,"startTime":"0","endTime":"0","summary":"国家知识产权局信息显示，比亚迪股份有限公司申请一项名为“车辆的控制方法、电子设备、车辆、介质及产品”的专利，公开号CN120942280A，申请日期为2025年07月。通过天眼查大数据分析，比亚迪股份有限公司共对外投资了108家企业，参与招投标项目1001次，财产线索方面有商标信息1820条，专利信息5000条，此外企业还拥有行政许可154个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115143323a4a31f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115143323a4a31f32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002594","81211","01211","BK1119","BK1607","BYDDY","HYDD.SI","BK1539","LU0326950275.SGD","LU0417516902.SGD","LU0819121731.USD","LU1023057109.AUD","LU0359201612.USD","LU1880383440.USD","LU0449515922.USD","LU0823426308.USD","LU0289961442.SGD","LU1868837565.USD","LU0165289439.USD","LU2097828714.EUR","00285","LU2097828805.USD","LU0229945570.USD","LU0531971595.HKD","LU0348767384.USD","LU0348766576.USD","BK1582","LU0823039010.USD","LU0449509016.USD","LU0634319403.HKD","LU0511384066.AUD","BK1515","LU1794554557.SGD","SG9999006597.SGD","LU0516422366.SGD","LU0211977185.USD","LU0828238088.HKD","LU0871576103.HKD","LU0315178854.USD","LU0650527681.SGD","LU0469268626.HKD","LU0516423091.SGD","LU0259732245.USD","LU0561508036.HKD","LU2348774022.SGD","LU0819123356.HKD","BK1594","LU0516423174.USD","LU0588546209.SGD","LU0516422952.EUR"],"gpt_icon":1},{"id":"2583635642","title":"因劳动合同纠纷，任能站起诉比亚迪等","url":"https://stock-news.laohu8.com/highlight/detail?id=2583635642","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583635642?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 09:07","pubTimestamp":1763168820,"startTime":"0","endTime":"0","summary":"近日，任能站新增一则开庭公告，案由为“劳动合同纠纷”，原告为任能站，被告为 比亚迪 股份有限公司、深圳市皇马劳务派遣有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115091817976a68f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115091817976a68f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0650527681.SGD","LU0516422952.EUR","LU0314109678.HKD","LU2039709279.SGD","SG9999015978.USD","LU2449936058.SGD","LU2097828474.EUR","LU0594300419.USD","LU0588545904.SGD","BK1582","LU0588545730.USD","LU0823414478.USD","LU0516423091.SGD","LU0823426480.USD","BK1580","LU0259732245.USD","LU0509642566.USD","002594","LU0274383008.USD","LU1328277881.USD","LU0054450605.USD","LU0828238088.HKD","LU1861214812.USD","LU0561508036.HKD","SG9999015945.SGD","LU0819123356.HKD","LU0359201612.USD","LU0289739343.SGD","01211","LU2294711713.HKD","BK1594","LU0359201885.HKD","BYDDY","LU1861219969.SGD","LU0327786744.USD","BK1522","LU0593848301.USD","SG9999002828.SGD","LU0516422440.USD","LU0348735423.USD","SG9999006514.SGD","HYDD.SI","LU0588545490.SGD","LU0572944931.SGD","BK1515","LU0289960550.SGD","LU0865486749.SGD","LU0214875030.USD","00285","81211"],"gpt_icon":0},{"id":"2583765244","title":"Tides 周递 | 全球多肽和寡核苷酸药物一周要闻（11.8-11.14）","url":"https://stock-news.laohu8.com/highlight/detail?id=2583765244","media":"多肽圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583765244?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 09:00","pubTimestamp":1763168442,"startTime":"0","endTime":"0","summary":"临床拟用于慢性乙型肝炎病毒感染的治疗。此外，SD 大鼠与食蟹猴的重复给药毒性试验显示，YKYY013 注射液具有良好的安全性和耐受性。该研究在263名不合并2型糖尿病的肥胖或伴有至少一种体重相关合并症的超重成人参与者中，评估了eloralintide的安全性与有效性。在第48周时，eloralintide各剂量组均达到主要终点，平均体重降幅为9.5%至20.1%，优于安慰剂组0.4%的平均降幅。研究显示，eloralintide可能通过影响饱腹感来减少热量摄入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115092746a4a2ad83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115092746a4a2ad83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1589","01672","BK1515","LU2328871848.SGD","HK0000165453.HKD","LU2097828805.USD","LU2097828557.USD","LU0455707207.USD","01801","LU2097828474.EUR","LU2097828714.EUR","LU0502904849.HKD","BK1574","BK1161","LU2488822045.USD","LU2097828631.EUR","LU2242644610.SGD","BK1583"],"gpt_icon":0},{"id":"2583307996","title":"康希诺施展财技：公积金一次性抹平14.5亿元亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2583307996","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583307996?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 08:24","pubTimestamp":1763166246,"startTime":"0","endTime":"0","summary":"11月7日，康希诺召开董事会会议，审议通过了关于使用公积金弥补亏损的议案，康希诺拟使用母公司盈余公积约1.18亿元和母公司资本公积约13.32亿元，两项合计约14.5亿元用于弥补母公司累计亏损。康希诺此次使用公积金弥补亏损后，为其未来可能进行的分红扫清了障碍。康希诺此次弥补的母公司未分配利润为负的原因主要为以前年度累计的亏损。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115075458976a4adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115075458976a4adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1191","06185","BK1161"],"gpt_icon":0},{"id":"2583633552","title":"出海速递：比亚迪领跑马来西亚电动车市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2583633552","media":"车质网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583633552?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 08:24","pubTimestamp":1763166240,"startTime":"0","endTime":"0","summary":"马来西亚：本土品牌Perodua稳居销冠，比亚迪领跑电动汽车市场据当地媒体报道，10月马来西亚汽车市场上本土品牌Perodua持续领跑，单月注册量达34,116辆，远超Proton 与丰田。值得关注的是，中国品牌比亚迪跻身10月品牌销量榜第五，显示出电动车在本地市场的持续增长潜力。菲律宾：电动汽车市场占比超6%，比亚迪推促销活动菲律宾电动汽车市场继续呈上升趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111508294295057058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111508294295057058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2357125470.USD","LU0469268626.HKD","LU0449515922.USD","SG9999001226.SGD","00285","81211","LU0315178854.USD","BK1594","LU0054450605.USD","LU0348805143.USD","LU1880383440.USD","LU0359202008.SGD","LU1868837565.USD","LU2097828557.USD","SG9999014674.SGD","LU0605514214.HKD","SG9999015945.SGD","002594","BK1540","LU0143863784.USD","LU0175139822.USD","LU0314109678.HKD","LU0417516902.SGD","LU2360107325.USD","LU1242518857.USD","LU2399975544.HKD","LU0516423174.USD","BK1610","HYDD.SI","01211","LU0509642566.USD","LU0828238088.HKD","LU0359201885.HKD","BK1515","LU0289960550.SGD","SG9999006597.SGD","LU0274383008.USD","LU0588545730.USD","LU0856984785.SGD","LU0449509016.USD","LU0516422366.SGD","LU0164865239.USD","LU0819121731.USD","BYDDY","LU0531971595.HKD","LU0229945570.USD","BK1522","LU0588545904.SGD","LU2294711713.HKD","IE00BD6J9T35.USD"],"gpt_icon":1},{"id":"2583022115","title":"人福医药：公司始终专注于医药主业的发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2583022115","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583022115?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 22:10","pubTimestamp":1763129400,"startTime":"0","endTime":"0","summary":"证券日报网讯人福医药（维权）11月14日在互动平台回答投资者提问时表示，公司始终专注于医药主业的发展，持续推进“归核聚焦”工作，优化资产结构，强化细分领域竞争优势。2025年前三季度，公司实现归母净利润16.89亿元，同比增长6.22%，2025年三季度末公司资产负债率降至40.53%，资产结构持续改善。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxktkn8977482.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxktkn8977482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1161","BK0070","600079","BK0188","BK0012","BK1574","BK0028","BK0096","BK1515","BK0239","BK0185","09939"],"gpt_icon":0},{"id":"2583542501","title":"国药控股主业遇冷，医药流通龙头的增长神话还能延续吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583542501","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583542501?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 21:23","pubTimestamp":1763126625,"startTime":"0","endTime":"0","summary":"作为国内医药流通行业的龙头企业，国药控股（股票代码：1099.HK）近期的业绩表现引发了市场的广泛关注。尽管其营收规模在行业内持续保持领先地位，但陷入净利润增长显著放缓的困境。业绩承压的背后，是公司三大核心业务板块集体面临增长挑战。作为营收“压舱石”的医药分销业务增长乏力，医疗器械板块同样未能摆脱增长瓶颈，就连曾被寄予厚望的医药零售业务，其增长也伴随着战略调整的阵痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511143565047652.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143565047652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","BK1500","LU0640798160.USD","BK1515","BK1161","09939","01099","LU1115378108.SGD","BK1574"],"gpt_icon":0},{"id":"2583344346","title":"能源仍是涨停热点板块！医药商业逆势崛起，补涨行情来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583344346","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583344346?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 20:51","pubTimestamp":1763124665,"startTime":"0","endTime":"0","summary":"涨停板方面，今日仍然有较多能源相关概念股涨停，具体来说则是锂电池板块和燃气板块。今日涨停最多的是医药板块，从细分行业来看，医药商业行业涨停股较多。当前医药商业板块现较多涨停股，不排除补涨的可能。市场预计将提振感冒药和流感相关药品的销售需求。主力资金净流入金额占市值比例排名前5的个股分别为中富通、日上集团、京能热力、康芝药业、英联股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114205647a6f99835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114205647a6f99835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02039","BK1161","BK1574","BK1507","09939","BK1183","BK1515"],"gpt_icon":0},{"id":"2583415680","title":"刚刚！PD-L1 皮下注射剂在国内获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2583415680","media":"丁香园肿瘤时间","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583415680?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 20:21","pubTimestamp":1763122912,"startTime":"0","endTime":"0","summary":"11 月 14 日，NMPA 官网显示，罗氏制药 PD-L1 单抗阿替利珠单抗皮下注射剂在国内获批上市。不仅如此，之前在英国获批时，该药也是海外最早获批的一款 PD-1 皮下注射剂。据 Insight 数据库显示，阿替利珠单抗皮下注射剂最早于2024 年 9 月在英国实现全球首批，目前也已经在欧盟、加拿大、美国都获批上市。而国内上市申请则在 2024 年 7 月 27 日获受理，今日成功获批上市。在肿瘤领域，罗氏合作 Halozyme 公司，目前有多达 9 个皮下注射抗体药项目在开发，7 款都已经获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114214339a6f9aeab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114214339a6f9aeab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01877","BK1583"],"gpt_icon":0},{"id":"2583503742","title":"科兴制药(688136.SH)：科益医药拟询价转让5%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503742","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583503742?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 20:15","pubTimestamp":1763122501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)披露股东询价转让计划书，本次拟参与本次询价转让的股东为科益医药，拟转让股份的总数为1006.28万股，占公司总股本的比例为5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1161","688136","159938","BK0239","09939"],"gpt_icon":0},{"id":"2583505330","title":"富祥药业：他唑巴坦、舒巴坦是公司主要医药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505330","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505330?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 20:09","pubTimestamp":1763122140,"startTime":"0","endTime":"0","summary":"证券日报网讯富祥药业11月14日发布公告，在公司回答调研者提问时表示，他唑巴坦、舒巴坦是公司主要医药产品，2024年销售收入占公司营业收入40%左右。而6-apa是他唑巴坦、舒巴坦的主要原材料，根据万得数据显示，截至2025年11月3日，6-apa价格较2024年底下降38%。随着其价格下降，将有效提升公司医药制造业务毛利率。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxkpau4340288.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxkpau4340288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK1515","09939","BK1161","BK1574","300497","159938","BK0201"],"gpt_icon":0},{"id":"2583968570","title":"下个月，460个化学药品，此地医保不予支付！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583968570","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583968570?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 20:00","pubTimestamp":1763121651,"startTime":"0","endTime":"0","summary":"今年6月，江苏省医保局已发布类似通知，931个中成药因价格违规，平台标示为挂网红色价格预警状态，医保统筹基金不予支付。苏州直接对红色预警的药品暂停医保支付，已经是仅次于撤网的最严厉处罚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114200333a6f97d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114200333a6f97d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287875.USD","LU1993786604.SGD","LU1008478684.HKD","LU1960683339.HKD","BK1515","LU1152091168.USD","LU0072913022.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1328277881.USD","IE0008368742.USD","SG9999004220.SGD","LU0067412154.USD","LU0326950275.SGD","LU1226287529.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU2039709279.SGD","BK1191","BK1521","LU1152091754.HKD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU0140636845.USD","HK0000165453.HKD","LU0314109678.HKD","IE0008369823.USD","01093","LU0880133367.SGD","LU1807302812.USD","LU1226288170.HKD","LU0315179316.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1226288253.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2583968049","title":"生物制造被提到新高度 创新药、中药等细分领域备受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2583968049","media":"金融投资报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583968049?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 19:56","pubTimestamp":1763121412,"startTime":"0","endTime":"0","summary":"有分析人士指出，未来，需求和供给仍将是医药行业的主要逻辑，建议关注创新药、医疗器械、中药、原料药、医疗服务等细分领域的投资机会。AI制图 卿子秀创新药：迈入双轮驱动阶段中国创新药行业已形成以领头企业为引领、大批量优质企业为支撑的金字塔梯队，产业兑现持续性强。截至2025年三季度末，申万中药行业机构持仓比例已低至0.2%，动态市盈率居2021年以来低位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114195858976955d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114195858976955d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","BK1574","01877","06978"],"gpt_icon":0},{"id":"2583567502","title":"涨价机会梳理：有色+锂电材料+化工+医药（机构闭门会议实录）","url":"https://stock-news.laohu8.com/highlight/detail?id=2583567502","media":"投研大叔","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583567502?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 19:39","pubTimestamp":1763120377,"startTime":"0","endTime":"0","summary":"电力设备及新能源板块：锂电池材料涨价趋势与FSI添加剂市场潜力中游锂电材料的供需紧张推动价格上涨，推荐关注FSI添加剂市场。锂电材料方面，铜箔和铝箔加工费上涨预期强烈，企业开工率回升，利润空间有望扩大。美国中期选举年，总统上任后到中期选举期间，大宗商品价格尤其是工业金属会出现持续上行趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114222645a4a1d773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114222645a4a1d773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09696","BK1161","LU1807302812.USD","09939","02899","BK1116","LU1960683339.HKD","LU1993786604.SGD","01772","BK1610","03750","BK1515","02600","BK1574","03347"],"gpt_icon":1},{"id":"2583508925","title":"新股消息 | 融泰药业拟港股上市 中国证监会要求补充说明近一年内新增股东入股价格的合理性等","url":"https://stock-news.laohu8.com/highlight/detail?id=2583508925","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583508925?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 19:32","pubTimestamp":1763119944,"startTime":"0","endTime":"0","summary":"中国证监会国际司公示10家企业补充材料要求，其中，公示提到要求融泰药业补充说明最近12个月内新增股东入股价格的合理性等事项。中国证监会请融泰药业补充说明以下事项，请律师核查并出具明确的法律意见：一、请说明最近12个月内新增股东入股价格的合理性，该等入股价格之间存在差异的原因，是否存在利益输送。据招股书，融泰药业是中国领先的院外医药服务商，专注于数字化营销和供应链解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1161","09939"],"gpt_icon":0},{"id":"2583168575","title":"石药巨石生物SYS6010启动II/III期临床 适应症为晚期/转移性食管鳞癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2583168575","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583168575?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 18:31","pubTimestamp":1763116260,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，石药集团巨石生物制药有限公司的评价SYS6010联合恩朗苏拜单抗注射液±5 - FU/卡培他滨治疗一线晚期/转移性食管鳞癌受试者的疗效和安全性的II/III期临床研究已启动。SYS6010为生物制品，适应症为晚期/转移性食管鳞癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111418374297693467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111418374297693467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1008478684.HKD","LU1951186391.HKD","SG9999004220.SGD","LU1152091754.HKD","LU1226287529.USD","IE00B031HY20.USD","LU1152091168.USD","IE00BZ08YR35.GBP","IE0008369823.USD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1328277881.USD","LU1226287875.USD","LU1807302812.USD","LU1960683339.HKD","LU0326950275.SGD","LU1993786604.SGD","LU0315179316.USD","LU0314109678.HKD","LU0140636845.USD","BK1515","LU1226288253.USD","IE00BZ08YS42.EUR","LU0067412154.USD","IE0008368742.USD","LU0880133367.SGD","LU1226288170.HKD","HK0000165453.HKD","01093","BK1191","LU2039709279.SGD","LU1813983027.USD","IE00B543WZ88.USD","LU0501845795.SGD","LU0072913022.USD","LU1226287792.SGD","BK1521"],"gpt_icon":0},{"id":"2583743885","title":"复星医药：公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2583743885","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583743885?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 17:55","pubTimestamp":1763114145,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问公司与美国梯瓦制药战略合作发展进展如何？是否已经盈利模式？复星医药（600196.SH）11月14日在投资者互动平台表示，截至目前，公司与美国梯瓦就在研药物TEV-56278的开发合作如期推进，相关药物于许可区域内尚处临床前阶段。如有后续重大进展，公司将根据上市地规则要求进行披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511143564906882.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143564906882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1191","02196","BK1593"],"gpt_icon":0},{"id":"2583579554","title":"比亚迪发布纯电动轿卡T4：以科技重塑物流，用温度赋能创富","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579554","media":"中国汽车报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583579554?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 17:07","pubTimestamp":1763111262,"startTime":"0","endTime":"0","summary":"而这正是轿卡T4要解决的核心命题——通过技术赋能，让创富之路不再充满艰辛。比亚迪轿卡T4的推出，是基于对全球卡友使用场景的深度洞察与技术积累的全面释放。在“双碳”目标与产业升级的双重机遇下，比亚迪用技术让电动化变得可感知，用创新让创富更有尊严和温度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114171356a4a13314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114171356a4a13314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1540","SG9999001226.SGD","LU0572944931.SGD","LU0314109678.HKD","LU2506951792.HKD","00285","LU0823414551.USD","BK1589","LU0164865239.USD","LU0165289439.USD","LU1242518857.USD","LU1868837565.USD","LU1023057109.AUD","LU0516422366.SGD","SG9999015986.USD","BYDDY","LU2449936058.SGD","LU0449509016.USD","LU0819123356.HKD","LU0708995583.HKD","LU1813983027.USD","LU0417516902.SGD","SG9999006514.SGD","BK1580","LU0865486749.SGD","LU1794554557.SGD","LU0143863784.USD","LU0326950275.SGD","002594","LU0594300179.USD","BK1594","BK1582","SG9999015978.USD","81211","LU0259732245.USD","LU0469268626.HKD","BK1504","LU0043850808.USD","LU0823426308.USD","LU0254981946.USD","LU0516423091.SGD","LU1328277881.USD","LU2476274720.SGD","HYDD.SI","BK1515","LU0516422440.USD","01211","LU0828238088.HKD","LU0084288322.USD","LU2476274308.USD"],"gpt_icon":1},{"id":"2583576177","title":"复星医药(600196.SH)控股子公司药品获美国FDA注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2583576177","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583576177?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 17:06","pubTimestamp":1763111217,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，近日，公司控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司自主研发的POHERDY1注射液的生物制品许可申请获美国FDA批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0060","BK0028","BK0196","BK1515","02196","BK0096","BK0175","BK1191","BK0183","600196","BK0239","BK0188","BK0187","BK1593"],"gpt_icon":0}],"pageSize":20,"totalPage":23,"pageCount":3,"totalSize":446,"code":"91000000","status":"200"}]}}